Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1999
11/25/1999WO1999059557A1 Multiparticulate pharmaceutical form with programmed and timed release and preparation method
11/25/1999WO1999059553A1 Effervescent preparations
11/25/1999WO1999059552A1 Regulated release preparations
11/25/1999WO1999059551A1 Pharmaceutical preparation containing levothyroxine sodium
11/25/1999WO1999059550A1 Novel particulate formulations
11/25/1999WO1999059549A1 Biodegradable sustained-release alginate gels
11/25/1999WO1999059548A1 Controlled drug delivery system using the conjugation of drug to biodegradable polyester
11/25/1999WO1999059546A1 A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier
11/25/1999WO1999059545A1 Targeted liposomal drug delivery system
11/25/1999WO1999059544A2 Orally disintegrable tablets
11/25/1999WO1999059542A1 Pectic preparations used as medicine carrier
11/25/1999WO1999059541A2 Cyclosporin preparations
11/25/1999WO1999052506B1 Particulate active agent support for pulmonary application
11/25/1999WO1999049844A3 Method for producing transdermal therapeutic systems by using basic alkali metal salts for converting active agent salts into free bases
11/25/1999WO1999048515A9 Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof
11/25/1999WO1999048480A3 Method for the production of micro capsules
11/25/1999WO1999047127A8 Hydrophilic and hydrophobic polyether polyurethanes and uses therefor
11/25/1999WO1999040771A3 Concurrent flow mixing for preparing compositions comprising gene therapy vectors
11/25/1999WO1999039740A9 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
11/25/1999WO1998018500A8 Improvements in or relating to diagnostic/therapeutic agents
11/25/1999DE19824306A1 Fibrin glue useful in tissue engineering, biotechnology and surgery
11/25/1999DE19823679A1 Herbal preparation useful for prophylaxis and/or therapy of tumors
11/25/1999DE19822509A1 Use of edelfosin for treatment of brain tumors, especially by oral administration
11/25/1999DE19820801A1 Oral dosage form for gatifloxacin, providing reproducible decomposition time and drug release
11/25/1999DE19819012A1 Feuersichere, nicht explosionsfähige, Nitroglycerin und wasserfreie Lactose enthaltende Feststoffmischungen Fire-proof, non-explosive, containing nitroglycerin and anhydrous lactose mixtures of solids
11/25/1999CA2587022A1 Orally disintegrable tablets
11/25/1999CA2333310A1 Use of tricyclic antidepressants for local analgesia
11/25/1999CA2333203A1 Methods for modulating neuronal cell death
11/25/1999CA2333193A1 Pharmaceutical preparation
11/25/1999CA2332802A1 Conjugate of therapeutic agent for joint disease and hyaluronic acid
11/25/1999CA2332649A1 Solid preparations for oral administration of drugs relating to genes
11/25/1999CA2332545A1 Novel particulate formulations
11/25/1999CA2332338A1 Hybrid polypeptides with enhanced pharmacokinetic properties
11/25/1999CA2332328A1 Compositions comprising organic mono- or dinitrate for treating impotence
11/25/1999CA2332270A1 Cyclosporin preparations
11/25/1999CA2329252A1 Compositions and methods for topical delivery of oligonucleotides
11/25/1999CA2329147A1 A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier
11/25/1999CA2329130A1 Compositions and methods for non-parenteral delivery of oligonucleotides
11/25/1999CA2328597A1 Display of viral proteins as ligands for cell-surface receptor
11/25/1999CA2328501A1 Prevention and treatment of hypergastrinemia
11/25/1999CA2328144A1 Multivalent t cell receptor complexes
11/25/1999CA2327314A1 Soluble t cell receptor
11/25/1999CA2327100A1 Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives
11/24/1999EP0959135A1 Display of viral proteins and targeted delivery to cellular receptor
11/24/1999EP0958823A1 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation
11/24/1999EP0958812A1 Spherical particle groups, process for preparing the same and spherical particulate pharmaceuticals using the same
11/24/1999EP0958380A1 Macromolecule-lipid complexes and methods for making and using
11/24/1999EP0958369A1 Cationic polymer and lipoprotein-containing system for gene delivery
11/24/1999EP0958361A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders
11/24/1999EP0958358A1 Method for preparing a plasmid dna
11/24/1999EP0958356A1 A process of making a compound by forming a polymer from a template drug
11/24/1999EP0958355A1 Transdermal transport of molecules
11/24/1999EP0958344A2 Compositions for disinfection of skin and mucous membrane
11/24/1999EP0957943A1 Matrix-free osteogenic devices, implants and methods of use thereof
11/24/1999EP0957940A1 Pharmaceutical compositions containing gellants in the form of alkyl amides of di- and tri-carboxylic acids
11/24/1999EP0957939A1 Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents
11/24/1999EP0957938A1 Composition with base of coconut oil and its use
11/24/1999EP0957931A1 Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant
11/24/1999EP0957929A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
11/24/1999EP0957927A1 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation
11/24/1999EP0957906A1 Local anesthetic for external use
11/24/1999EP0957901A1 Pharmaceutical preparations of glutathione and methods of administration thereof
11/24/1999EP0957900A1 Compositions and methods for topical application of therapeutic agents
11/24/1999EP0892632A4 Compositions useful in the phototherapeutic treatment of proliferative skin disorders
11/24/1999EP0749446B1 Highly reactive esters of carboxy polysaccharides and novel carboxy polysaccharides derived therefrom
11/24/1999EP0730470A4 Improved interferon polymer conjugates
11/24/1999EP0666901A4 Method and compositions for removing an alginate from a cutaneous substrate.
11/24/1999EP0662836B1 Germicidal detergent-iodine compositions having reduced detergent content
11/24/1999EP0650366B1 Compositions and methods for treating wounds
11/24/1999CN1236317A Stable aspirin ointment preparations
11/24/1999CN1236316A Stable aspirin-containing preparations for external use
11/24/1999CN1235846A Medicine preparation administrated through nasal mucosa
11/24/1999CN1235833A Novel drug composition for treating and curing and its preparing method
11/24/1999CN1046691C Method for colouring piece of rock by laser rays
11/24/1999CN1046635C Composition and mether using nitrooxides to avoid oxygen toxicity
11/24/1999CN1046632C Method for preparing injectable preparation containing cephalosporin medicament
11/23/1999US5990297 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
11/23/1999US5990296 Improving binding affinity of single chain lewis-y antibodies by replacing amino acid at position 95 with serine; immunotoxins for anticarcinogenic/antitumor agents
11/23/1999US5990287 Immunoglobulin which binds to surface antigen of stomach cancer cell mnk45 and colon cancer cell c-1; for diagnosis of cancer; for anticarcinogenic agents and immunotoxins
11/23/1999US5990285 Catalytic antibodies against cocaine
11/23/1999US5990274 Cyclosporine derivatives and uses thereof
11/23/1999US5990241 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
11/23/1999US5990237 Conjugating a water-soluble polymer to a biomolecule or drug having an amine group by activating the polymer by reacting with a halide-containing acetal followed by hydrolysis; purity; by-product inhibition
11/23/1999US5990194 Biodegradable in-situ forming implants and methods of producing the same
11/23/1999US5990180 Solubilizer or dispersant of a polyglycerol saturated fatty acid ester; storage stability; transportation; oil-soluble e.g., colorants, flavoring materials, vitamins, antioxidants, preservervatives, bactericides; oils and fats
11/23/1999US5990176 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
11/23/1999US5990141 Administering 5-methyl-isoxazole-4-carboxylic acid-n-(4-trifluoromethyl)anilide or 2-cyano-3-hydroxy-n-(4-trifluoro-methyl)phenyl-2-butenamide; antitumor,-carcinogenic and proliferative agents; kinase inhibitors
11/23/1999US5990100 Composition and method for treatment of psoriasis
11/23/1999US5990098 Therapeutic use of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid and its salts
11/23/1999US5990096 Formulations containing hyaluronic acid
11/23/1999US5990095 Use of hyaluronic acid and forms to prevent arterial restenosis
11/23/1999US5990089 Introducing a polynucleotide into a eukaryotic cell in a living animal comprising contacting the cell with a composition comprising a polynucleotide and a dendrimer polycation coupled to the polynucleotide
11/23/1999US5990081 Purified with an immobilized compound with 2 or 3 nitrogen atoms strongly attaches the endotoxins, and thereby the apoliproteins (apo a or apo e) to the matrix; elution with a surfactant solution releases apo; cardiovascular disorders
11/23/1999US5989596 Applying composition containing a sulfite and a plant extract
11/23/1999US5989591 Dosage unit containing poloxamer and sucrose overcoat
11/23/1999US5989566 Stable vaccine compositions for parenteral administration, a method for their use, and a process for their preparation
11/23/1999US5989563 Viral agent associated with mystery swine disease
11/23/1999US5989545 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
11/23/1999US5989539 Compounds and compositions for delivering active agents
11/23/1999US5989536 Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin
1 ... 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 ... 1712